Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

Abstract Background Selecting the appropriate patients to receive immunotherapy (IO) remains a challenge due to the lack of optimal biomarkers. The presence of liver metastases has been implicated as a poor prognostic factor in patients with metastatic cancer. We investigated the association between...

Full description

Bibliographic Details
Main Authors: Mehmet Asim Bilen, Julie M. Shabto, Dylan J. Martini, Yuan Liu, Colleen Lewis, Hannah Collins, Mehmet Akce, Haydn Kissick, Bradley C. Carthon, Walid L. Shaib, Olatunji B. Alese, Conor E. Steuer, Christina Wu, David H. Lawson, Ragini Kudchadkar, Viraj A. Master, Bassel El-Rayes, Suresh S. Ramalingam, Taofeek K. Owonikoko, R. Donald Harvey
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Cancer
Subjects:
Immunotherapy
Phase 1 clinical trials
Sites of metastasis
Liver metastasis
Clinical outcomes
Tumor immunology
Online Access:http://link.springer.com/article/10.1186/s12885-019-6073-7

Internet

http://link.springer.com/article/10.1186/s12885-019-6073-7

Similar Items